Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cryo-Cell Intl Inc (CCEL)

Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,784
  • Shares Outstanding, K 8,104
  • Annual Sales, $ 31,340 K
  • Annual Income, $ -9,520 K
  • 60-Month Beta 0.45
  • Price/Sales 1.91
  • Price/Cash Flow 11.07
  • Price/Book N/A
Trade CCEL with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.51 +21.66%
on 04/17/24
8.15 -2.82%
on 03/28/24
+1.51 (+23.56%)
since 03/22/24
3-Month
4.47 +76.98%
on 02/23/24
8.15 -2.82%
on 03/28/24
+2.74 (+52.90%)
since 01/22/24
52-Week
3.67 +115.80%
on 11/16/23
8.15 -2.82%
on 03/28/24
+4.21 (+113.32%)
since 04/21/23

Most Recent Stories

More News
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first...

CCEL : 7.92 (+5.60%)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 7.92 (+5.60%)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 7.92 (+5.60%)
Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 7.92 (+5.60%)
Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 7.92 (+5.60%)
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 7.92 (+5.60%)
Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 7.92 (+5.60%)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 7.92 (+5.60%)
Cryo-Cell International Announces Changes To Its Board of Directors

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy...

CCEL : 7.92 (+5.60%)
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company’s Common Stock Has Been Approved For Listing On The Nasdaq...

CCEL : 7.92 (+5.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the...

See More

Key Turning Points

3rd Resistance Point 8.67
2nd Resistance Point 8.40
1st Resistance Point 8.16
Last Price 7.92
1st Support Level 7.66
2nd Support Level 7.39
3rd Support Level 7.15

See More

52-Week High 8.15
Last Price 7.92
Fibonacci 61.8% 6.44
Fibonacci 50% 5.91
Fibonacci 38.2% 5.38
52-Week Low 3.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar